occurs in has participant quality has disease treated with drug CLOPIDOGREL MONTELUKAST ESZOPICLONE LISINOPRIL MITOXANTRONE HYDROCHLORIDE PENTAMIDINE SIMVASTATIN PRAVASTATIN LOSARTAN POTASSIUM RITUXIMAB INFLIXIMAB LEFLUNOMIDE ROFECOXIB PANTOPRAZOLE LINEZOLID ZIPRASIDONE VALGANCICLOVIR VALDECOXIB TINIDAZOLE LENALIDOMIDE NILOTINIB TOCILIZUMAB secondary progressive multiple sclerosis pain agnosia Cytomegalovirus retinitis hypertension pneumocystosis Wegener's granulomatosis peptic esophagitis asthma bacterial vaginosis sleep disorder schizophrenia myocardial infarction congestive heart failure juvenile rheumatoid arthritis rheumatoid arthritis osteoarthritis chronic myeloid leukemia ulcerative colitis bacterial pneumonia intermediate coronary syndrome multiple myeloma Elderly Child Adult upper respiratory tract infection AE 10046300 an infection AE is a respiratory system AE that results in illnesses caused by an acute infection which involves the upper respiratory tract: nose, sinuses, pharynx or larynx CTCAE: E11604 SIDER: C0041912 SS, YH NCIt: C35650 HPO: HP_0002788 URI, URTI WEB: http://en.wikipedia.org/wiki/Upper_respiratory_tract_infection infection AE AE severity G2 AE severity G3 AE severity G4 AE severity G5 upper respiratory tract